Drawing for BELOVIO

USPTO serial 79286496

BELOVIO

Reviewed by CopyMark Law Group

Reg. 6213717Status 700Renewal
Filing date
Status date
Registration date
Dec 8, 2020
Examiner
PIERCE, ALEXANDRA
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with BELOVIO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,046*

Plus Government fees of $1,300

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

William C. Wright

William C. Wright Epstein Drangel LLP60 East 42nd Street, Suite 2520New York, NY 10165UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Scientific research and laboratory apparatus, namely, apparatus to analyze hormone level in urine and ultrasound system for medical research use in the field of Fertility; Research laboratory measuring, detecting and monitoring instruments for measuring, detecting and monitoring the hormone level in Urine, hormone injection data and growth of embryos in the female body; Information technology for medical use in the field of Fertility, namely, downloadable software based apps for exchange of medical dataACTIVE—
010Medical analytical apparatus for medical purposes; apparatus for producing ultrasonic waves for medical application; applicators for medications, namely, prefilled syringes sold filled with follicle stimulating hormones; automatic analyzers for analyzing hormone injection data and hormone level in urine for medical diagnosis; diagnostic apparatus for medical purposes; all of the aforementioned goods in the field of fertilityACTIVE—
038Providing access to websites on the Internet or any other communications network; provision of access to data or documents stored electronically in central files for remote consultationACTIVE—
044Medical screening; medical analysis for the diagnosis and treatment of persons; medical services in the field of fertility; providing information relating to the treatment of infertilityACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 8, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Apr 5, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 12, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 12, 2021FIMPFINAL DISPOSITION PROCESSED—
Mar 8, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 8, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 22, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 22, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 2, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 18, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 18, 2020XAECEXAMINER'S AMENDMENT ENTERED—
Aug 18, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 18, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 18, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 24, 2020RFNTREFUSAL PROCESSED BY IB—
Jul 17, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 16, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 16, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 8, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 7, 2020RFRRREFUSAL PROCESSED BY MPU—
Jun 4, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 3, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 2, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
May 29, 2020DOCKASSIGNED TO EXAMINER—
May 29, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 28, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance